Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Bora Oh"'
Autor:
Ju Hyun Shim, Chang Ohk Sung, Jae-Seung Kim, Ha Il Kim, Jin Hwa Jung, Wonkyung Kim, Ji-Hye Oh, Bora Oh, Yoo-Jin Oh, Seog-Young Kim, Minyoung Oh, Jihyun An
Purpose:This work aimed to explore in depth the genomic and molecular underpinnings of hepatocellular carcinoma (HCC) with increased 2[18F]fluoro-2-deoxy-d-glucose (FDG) uptake in PET and to identify therapeutic targets based on this imaging-genomic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b354d25a34a7af1ddab8ffe1633a5b
https://doi.org/10.1158/1078-0432.c.6532625.v1
https://doi.org/10.1158/1078-0432.c.6532625.v1
Autor:
Ju Hyun Shim, Chang Ohk Sung, Jae-Seung Kim, Ha Il Kim, Jin Hwa Jung, Wonkyung Kim, Ji-Hye Oh, Bora Oh, Yoo-Jin Oh, Seog-Young Kim, Minyoung Oh, Jihyun An
Supplementary Data from PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12751694d231990b4e1c126859cdcffa
https://doi.org/10.1158/1078-0432.22487987
https://doi.org/10.1158/1078-0432.22487987
Autor:
Ju Hyun Shim, Chang Ohk Sung, Jae-Seung Kim, Ha Il Kim, Jin Hwa Jung, Wonkyung Kim, Ji-Hye Oh, Bora Oh, Yoo-Jin Oh, Seog-Young Kim, Minyoung Oh, Jihyun An
Supplementary Figure from PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05eff8d2ef53e667a2995bb220c14938
https://doi.org/10.1158/1078-0432.22487981.v1
https://doi.org/10.1158/1078-0432.22487981.v1
Autor:
Jihyun An, Ji-Hye Oh, Bora Oh, Yoo-Jin Oh, Jin-Sung Ju, Wonkyung Kim, Hyo Jung Kang, Chang Ohk Sung, Ju Hyun Shim
Publikováno v:
Hepatology (02709139); Aug2023, Vol. 78, p452-467, 16p
Autor:
Eun Jung Lee, Bora Oh, Chang Ohk Sung, Deokhoon Kim, Gi-Won Song, Jihyun Song, Naomi Park, Yoo-Jin Oh, Jihyun An, Won-Kyung Kim, Ji-Hye Oh, Han Chu Lee, Ju Hyun Shim, Eric Letouzé, Hyo Jeong Kang, Eunsil Yu, Jessica Zucman-Rossi, Ha Ii Kim, Dae Ghon Kim
Publikováno v:
Hepatology. 75:997-1011
Despite the epidemiological association between intrahepatic cholangiocarcinoma (iCCA) and HBV infection, little is known about the relevant oncogenic effects. We sought to identify the landscape and mechanism of HBV integration, along with the genom
Autor:
Jihyun An, Ji‐Hye Oh, Bora Oh, Yoo‐Jin Oh, Jin‐Sung Ju, Wonkyung Kim, Hyo Jung Kang, Chang Ohk Sung, Ju Hyun Shim
Publikováno v:
Hepatology (Baltimore, Md.)REFERENCES.
We performed an in-depth examination of pathogenic germline variants (PGVs) and somatic variants in DNA damage response (DDR) genes in hepatocellular carcinoma (HCC) to explore their clinical and genomic impacts.We used a merged whole-exome or RNA se
Autor:
Yoo-Jin Oh, Bora Oh, Won-Kyung Kim, Chang Ohk Sung, Hee Sang Hwang, Hyo Jeong Kang, Ju Hyun Shim, Eunsil Yu, Ji Hye Oh, Jihyun An
Publikováno v:
Annals of Surgical Oncology. 28:6466-6478
Although hepatocellular carcinomas (HCCs) often recur in patients undergoing hepatectomy, there are no reliable biomarkers of this undesirable event. Recent RNA-based efforts have developed valuable genetic indices prognostic of cancer outcomes. We a
Autor:
Yoo-Jin Oh, Ha Il Kim, Bora Oh, Won-Kyung Kim, Chang Ohk Sung, Jihyun An, Ji-Hye Oh, Ju Hyun Shim
Publikováno v:
Gut. 71:1234-1236
Early diagnosis of hepatocellular carcinoma (HCC) increases the chances of curative treatment and long-term survival.1 2 We read with interest the analytical study by Zhang et al presenting nomogram models predicting recurrence-free survival and guid
Publikováno v:
Korean Association For Learner-Centered Curriculum And Instruction. 20:883-908
Autor:
Jihyun An, Minyoung Oh, Seog-Young Kim, Yoo-Jin Oh, Bora Oh, Ji-Hye Oh, Wonkyung Kim, Jin Hwa Jung, Ha Il Kim, Jae-Seung Kim, Chang Ohk Sung, Ju Hyun Shim
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(9)
Purpose: This work aimed to explore in depth the genomic and molecular underpinnings of hepatocellular carcinoma (HCC) with increased 2[18F]fluoro-2-deoxy-d-glucose (FDG) uptake in PET and to identify therapeutic targets based on this imaging-genomic